During the past decade, Division of Cardiology Ao Moscati conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Division of Cardiology Ao Moscati" are "Acute Myocardial Infarction" (1 trials) and "ST Elevation Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Division of Cardiology Ao Moscati" in a lesser frequency.

Most popular intervention types in "Division of Cardiology Ao Moscati" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bioresorbable vascular scaffold" (1 trials), "Everolimus eluting stent" (1 trials), "everolimus eluting stent" (1 trials) and "sirolimus eluting stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Division of Cardiology Ao Moscati" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Division of Cardiology Ao Moscati". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Division of Cardiology Ao Moscati, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Division of Cardiology Ao Moscati, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".